Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 1997

View Archived Issues

Eisai: Annual Report 1997

LXR issued two U.S. patents for naturally occurring death receptor

AF-1 stimulates CNS regeneration in animal models; proof of principle established

ArQule and Acacia to develop novel drug candidates

CoCensys and Warner-Lambert renew and expand neurologic drug development collaboration

New estrogen receptor ligand reported by Glaxo Wellcome

Merck & Co.: Q3 1997 highlights

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Patents issued to Corvas for serine protease inhibitors

Romozin now available in U.K.

Zorac introduced in U.K. for psoriasis

Cephalon and Kyowa Hakko issued patents on neurotrophic small molecules

Aronex receives grants for development of HIV integrase inhibitor

Dopamine D1 agonists improve spatial working memory in aged monkeys

Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor

FDA clears generic transdermal nicotine product

PathoGenesis initiates phase II trial with new antiinfective for tuberculosis

NeoPharm moves LED to phase I for prostate cancer

Mechanism of cytoprotective effects of bimoclomol

Procept completes phase I testing with PRO-2000 gel

OraVax to develop new treatments for Clostridium difficile-associated disease

Nymox's urinary test for Alzheimer's disease successfully completes initial trials

Zeneca introduces zolmitriptan in Germany

German launch for Roche's mibefradil

Endocrinologic and Metabolic Drugs Advisory Committee meets in late November

Axcan completes phase III trial for H. pylori eradication

FDA advisory committee to review finasteride for alopecia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...